OncoFusion Therapeutics

Healthcare 📍 Ann Arbor, United States 👥 11-50 employees 💰 $525K raised 📅 Founded 2012

OncoFusion Therapeutics Inc. discovers and develops personalized therapeutics for patients with genetically defined cancers. It focuses on bromodomain inhibitors, ERG inhibitors, EZH-2-EED inhibitors, and MMSET/NSD 2 inhibitors. The company was founded in 2012 and is based in Ann Arbor, Michigan.

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

11-50

Total Raised · Debt

$525K

Founded

2012

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from OncoFusion Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction